No material LLY-specific news briefings with verified dates were available in the 30-day window preceding this report's generation date of 27 September 2026. A broader macro briefing dated 14 September 2026 noted that Brent crude rose to $108 per barrel, approximately 3% on the day, amid Middle East supply disruptions and firming Federal Reserve rate hike expectations [Brief - 2026-09-14]. No company-specific announcements, product updates, or regulatory decisions for Eli Lilly were confirmed within the available briefing data for this period [Brief - 2026-09-19].
Eli Lilly's trailing twelve-month revenue as of 30 June 2026 stood at $79.67 billion, representing year-over-year growth of approximately 47.7%. Net income for the same period was $26.71 billion, producing a net margin of 33.5%. EPS grew 26.2% year-over-year. The company held $8.95 billion in cash against total debt of $54.91 billion. The reported P/E ratio was 39.71. These figures reflect the period ending 30 June 2026 [SEC 10-Q - LLY - 2026-06-30].
Seven insider transactions were recorded in September 2026, with a mixed net direction and a net value of zero, indicating no pronounced one-directional insider activity during the period [SEC Form 4 - LLY - 2026-09]. Institutional ownership changes were notable across multiple filers. ARK Invest added 509% to its LLY position, Citadel added 46%, Bridgewater added 23%, and AQR Capital added 21%. Millennium reduced its position by 14%. These disclosures collectively represent the material institutional position changes that motivated this report [SEC 13F - Citadel - Q3 2026] [SEC 13F - AQR Capital - Q3 2026] [SEC 13F - Millennium - Q3 2026] [SEC 13F - Bridgewater - Q3 2026] [SEC 13F - ARK Invest - Q3 2026].
The 10-year US Treasury yield stood at 5.18% and the 2-year yield at 4.87%, producing a normal yield curve spread of approximately 31 basis points [FRED DGS10] [FRED DGS2]. This rate environment forms the prevailing macro backdrop against which Lilly's debt load of $54.91 billion and financing costs are assessed. The firming of Federal Reserve rate expectations, referenced in the 14 September 2026 briefing, remains a relevant macro variable for large-cap, debt-carrying issuers across the sector [Brief - 2026-09-14].